Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

The U.S. Food and Drug Administration on Friday agreed to reconsider its recent decision barring drug compounders from ...

Eli Lilly (LLY) is calling on companies that have been selling off-brand versions of its popular diabetes and weight-loss ...

The two-year shortage of Eli Lilly’s blockbuster weight-loss and diabetes drugs is over, the U.S. Food and Drug ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

Currently, the only FDA-approved OTC weight loss drug is Alli, which uses a 60-milligram dose of orlistat versus 120 ...

A dietitian shares the science-backed weight loss supplements that support weight loss when paired with a balanced diet and active lifestyle.

Finding the right solution for weight loss can feel overwhelming, especially with so many options available. While ...

Affiliate content. See how LeanBliss and SuperThin stack up against each other when it comes to weight loss support.

The pharmaceutical industry has seen a tremendous surge in the development of weight loss drugs, particularly GLP-1 receptor ...

Zepbound (tirezepatide) is another popular, FDA-approved weight loss injection ... talk through your health profile and weight loss goals and recommend best options. ConsumerAffairs is not ...

WeightWatchers (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) announced today the addition of compounded semaglutide into its offering, broadening eligible members’ access to clinical weight ...